Literature DB >> 16421980

Pharmacogenetics, pharmacogenomics and ecogenetics.

Arno G Motulsky1, Ming Qi.   

Abstract

Pharmacogenetics and pharmacogenomics deal with the role of genetic factors in drug effectiveness and adverse drug reactions. The promise of a personalized medicine is beginning to be explored but requires much more clinical and translational research. Specific DNA abnormalities in some cancers already have led to effective targeted treatments. Racially determined frequency differences in pharmacogenetic traits may affect choice of treatment requiring specific testing rather than basing treatments according to racial designation. The role of genes in variable responses to foreign chemicals (xenobiotics) has been termed ecogenetics or toxicogenetics raising problems in public health and occupational medicine. Nutrigenetics refers to genetic variation in response to nutrients and may affect nutritional requirements and predisposition to chronic disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421980      PMCID: PMC1363768          DOI: 10.1631/jzus.2006.B0169

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  10 in total

1.  From pharmacogenetics and ecogenetics to pharmacogenomics.

Authors:  Arno G Motulsky; Arno G Motuslky
Journal:  Med Secoli       Date:  2002

Review 2.  Inheritance and drug response.

Authors:  Richard Weinshilboum
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

3.  Drug reactions enzymes, and biochemical genetics.

Authors:  A G MOTULSKY
Journal:  J Am Med Assoc       Date:  1957-10-19

4.  Pharmacogenomics. Cancer sharpshooters rely on DNA tests for a better aim.

Authors:  Jennifer Couzin
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

5.  First phase of HapMap project already helping drug discovery.

Authors:  Mariam Andrawiss
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

Review 6.  Priorities and standards in pharmacogenetic research.

Authors:  Anna C Need; Arno G Motulsky; David B Goldstein
Journal:  Nat Genet       Date:  2005-07       Impact factor: 38.330

7.  Human genetic variation and nutrition.

Authors:  A G Motulsky
Journal:  Am J Clin Nutr       Date:  1987-05       Impact factor: 7.045

Review 8.  Will tomorrow's medicines work for everyone?

Authors:  Sarah K Tate; David B Goldstein
Journal:  Nat Genet       Date:  2004-11       Impact factor: 38.330

Review 9.  Pharmacogenomics and "individualized drug therapy": high expectations and disappointing achievements.

Authors:  Daniel W Nebert; Lucia Jorge-Nebert; Elliot S Vesell
Journal:  Am J Pharmacogenomics       Date:  2003

10.  Genetic control of drug levels in man: phenylbutazone.

Authors:  E S Vesell; J G Page
Journal:  Science       Date:  1968-03-29       Impact factor: 47.728

  10 in total
  5 in total

1.  Knowledge, Perception, and Application of Pharmacogenomics Among Hospital Pharmacists in Saudi Arabia.

Authors:  Mohammed Algahtani
Journal:  Risk Manag Healthc Policy       Date:  2020-08-21

Review 2.  Emerging roles for pharmacists in clinical implementation of pharmacogenomics.

Authors:  Aniwaa Owusu-Obeng; Kristin W Weitzel; Randy C Hatton; Benjamin J Staley; Jennifer Ashton; Rhonda M Cooper-Dehoff; Julie A Johnson
Journal:  Pharmacotherapy       Date:  2014-09-15       Impact factor: 4.705

3.  Comparison of Nonlinear Mixed Effects Models and Noncompartmental Approaches in Detecting Pharmacogenetic Covariates.

Authors:  Adrien Tessier; Julie Bertrand; Marylore Chenel; Emmanuelle Comets
Journal:  AAPS J       Date:  2015-02-20       Impact factor: 4.009

Review 4.  Pharmacogenetics, pharmacogenomics and ayurgenomics for personalized medicine: a paradigm shift.

Authors:  Pooja D Gupta
Journal:  Indian J Pharm Sci       Date:  2015 Mar-Apr       Impact factor: 0.975

Review 5.  Perspective on the Genetic Response to Antiparasitics: A Review Article.

Authors:  Patricia Alarcon-Valdes; Mariana Ortiz-Reynoso; Jonnathan Santillan-Benitez
Journal:  Iran J Parasitol       Date:  2017 Oct-Dec       Impact factor: 1.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.